![Asthma / Respiratory therapy / Combination drugs / Dosage forms / GlaxoSmithKline / Formoterol / Mometasone/formoterol / Fluticasone/salmeterol / Mometasone furoate / Medicine / Pulmonology / Pharmacology Asthma / Respiratory therapy / Combination drugs / Dosage forms / GlaxoSmithKline / Formoterol / Mometasone/formoterol / Fluticasone/salmeterol / Mometasone furoate / Medicine / Pulmonology / Pharmacology](https://www.pdfsearch.io/img/9c5b4c823edd6a2bcb4d01a1d2af1932.jpg)
| Open Document File Size: 1,69 MBShare Result on Facebook
Company Formoterol Ae / Novartis / Schering-Plough / / Country United States / / Currency pence / / Event FDA Phase / / IndustryTerm fixed dose combination product / Review product / combination product / formulation device / drug products / / MarketIndex AUC / / MedicalCondition bronchospasm / COPD / disease / persistent asthma / nocturnal asthma / COPD Patients / inflammatory / Asthma / / MusicGroup Ph.D. / / Organization Clinical Division / OCP Division / office of Clinical Pharmacology / / Person Tien-Mien Chen / Liang Zhao / Ying Fan / Partha Roy / / / Position Team Leader / EXECUTIVE / General / controller / / Product Fluticasone Propionate / mometasone furoate / FORADIL / DCP-2 / P04689 / Dulera / Asmanex® / US / Asmanex / Dulera® / ASMANEX® TWISTHALER / sponsor / / ProvinceOrState Indiana / / PublishedMedium Parameters / / Technology pharmacokinetics / pharmacodynamics / drug development / /
SocialTag |